MAM
HT Media announces leadership change: Sameer Singh to succeed Praveen Someshwar as group CEO
MUMBAI: – HT Media’s board of directors, in a meeting held on 11 January, accepted the resignation of managing director & CEO Praveen Someshwar, effective 28 February 2025. The board has approved the appointment of Sameer Singh as group chief executive officer, effective 1 March 2025, based on the recommendation of the nomination and remuneration committee.
An alumnus of IIM Calcutta, Sameer Singh brings over 30 years of experience in digital innovation, brand marketing, and leadership across global markets. He currently heads north America global business solutions at TikTok/ByteDance, leading advertising and sales teams for the region. Previously, he held a similar leadership role for the Asia-Pacific region.
Sameer has an impressive track record in media and marketing, having served as CEO of GroupM India and south Asia, where he championed digital transformation and content-driven strategies for clients. His career also includes key roles at Google, GSK, Procter & Gamble, and IPG, where he was instrumental in advancing digital strategies and optimising media investments.
Having worked in cities such as New York, New Delhi, Palo Alto, Boston, London, Dubai, and Guangzhou, Sameer’s global perspective and expertise make him a strategic choice to lead HT Media into its next phase of growth.
The leadership transition marks a significant step for HT Media as it continues to evolve in a rapidly changing media landscape.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
